People · Operator
Named in public records as an officer, director or promoter · active 2017–2022 · Biotechnology, Biotech / Pharma, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cytovale Inc. | — | Biotechnology | Series B | $31.1M | $533.9M | 2017 |
| Surf Bio, Inc. | — | Biotech / Pharma | Series B | $16.0M | $287.6M | 2022 |
| Common Scents, Inc. | — | Other | Seed | $2.0M | $20.9M | 2022 |
Lindy Fishburne at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Lindy Fishburne on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ajay Shah | 1 | 7 |
| JACK FUCHS | 1 | 6 |
| Ben Askew | 1 | 3 |
| Bryan Mazlish | 1 | 2 |
| Jennifer Schneider | 1 | 2 |
| Jordanna Polis Schutz | 1 | 1 |
| Peter Ledochowitsch | 1 | 1 |
| Dino DiCarlo | 1 | 1 |
| William Blackledge | 1 | 1 |
| Henry Tse | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.